Hyundai Bioscience Co., Ltd.

₩5,640As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:048410Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 8.31%
Div yield —
ROE (24.29%)
Biotechnology
Beta (5Y) 1.09
PE TTM —
TSR TTM 4.02%
Mkt cap ₩544.3B
ROIC (22.32%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,978
23.73%
(82.72%)
Sell 8|4|8|11|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
96.31
97.16
97.27
107.39
7.77%
2.81%
(0.29%)
11.02%
Revenue₩B
25.35
25.56
26.26
26.55
8.97%
10.10%
9.67%
8.74%
Peers (US$401.3M)
Cap (US$)
PE
447.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.216
(0.693)
(0.620)
EBIT/Intx
5.625
0.560
0.597
Own earn%
41.69
68.67
(5.84)
Sh yield%
40.01
35.24
32.16
Owners
Insiders/Inst%
12.55
86.83
Short interest%
4.17
SBC / revenue%
4.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
10–16
$1 testx
—
Incr. ROIC%
0